as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹156.23
Change
-1.69 (-1.07%)
Open
₹157.92
Prev. Close
₹157.92
Day High
₹159.11
Day Low
₹154.01
Volume Analysis
Traded
138,169
Delivered
58,501
Delivery %
42.34%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹163.99 | ₹161.55 | ₹158.89 | ₹156.45 | ₹153.79 | ₹151.35 | ₹148.69 |
| Fibonacci | ₹161.55 | ₹159.6 | ₹158.4 | ₹156.45 | ₹154.5 | ₹153.3 | ₹151.35 |
| Camarilla | ₹157.63 | ₹157.17 | ₹156.7 | ₹156.45 | ₹155.76 | ₹155.3 | ₹154.83 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
-2.63%
1 Month
+13.17%
3 Months
—
6 Months
—
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 23 Sep 2026. Not investment advice.
TopFund Analysis
K M C Speciality Hosp I L lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 50/100. The strongest factor is Corporate Governance (85/100), while Liquidity (26/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
50/100 — AverageData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Corporate Governance
Institutional Ownership
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Newspaper Advertisement for the 43rd Annual General Meeting of the Company.
Submitted BRSR for FY 2025-26 under Regulation 34.
Annual report 2025-26 and 43rd AGM scheduled for 28 September 2026 via VC/OAVM.
Source: BSE regulatory filings, via Screener.in.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 24.99% | 25.0% | 25.0% | 24.99% | 24.98% | 25.0% | 25.0% | 25.0% | 25.0% | 24.99% | 25.01% | 24.98% |
| Promoters | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.01% | 0.0% | 0.0% | 0.0% | 0.0% | 0.02% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| K M C Speciality Hosp I L (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 444,405 | 35.2 | 5.32 | 16.0% |
| Divi S Laboratories Ltd | 255,487 | 85.8 | 15.25 | 16.5% |
| Torrent Pharmaceuticals L | 189,746 | 85.0 | 20.11 | 27.4% |
| Apollo Hospitals Enter. L | 128,055 | 60.9 | 13.51 | 21.2% |
| Zydus Lifesciences Ltd | 120,089 | 24.7 | 4.48 | 21.2% |
| Cipla Ltd | 111,060 | 31.0 | 3.23 | 11.6% |
Which Mutual Funds Hold K M C Speciality Hosp I L?
Frequently Asked Questions about K M C Speciality Hosp I L
K M C Speciality Hosp I L (KMCSHIL) closed at ₹156.23 on NSE on 25 September 2026, down 1.69 (1.07%) from the previous close.
K M C Speciality Hosp I L trades on the NSE (National Stock Exchange of India) under the symbol KMCSHIL.
K M C Speciality Hosp I L has a TopFund Quality Score of 50/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about K M C Speciality Hosp I L?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.